All Categories
- 2021 Vision
- AI in Medicine
- Alternative Therapies
- Alzheimer(s) Disease
- Anxiety
- Art in Healthcare
- Autism
- Autoimmune Disorders
- BigData
- Biotech
- BIPOC Founders
- Blockchain
- Breast Cancer
- Cancer Care
- Cardiovascular Disease
- Clinical Interventions
- Clubhouse
- Coaching
- Community
- Connected Health
- COVID-19
- Dental
- Depression
- Diabetes
- Diagnostics
- Drug Development
- Emergency Medicine
- Equity Raise
- Family Caregivers
- Female Founders
- Fitness or Wellness
- For the Doctors Office
- Genetic Disorders
- Geriatric Medicine
- Hard to Categorize
- Healthy Living
- HIT
- Home-Based Care
- Hospital Solutions
- Infectious Disease
- Informatics
- InsureTech
- Interoperability
- LGBTQIA Founders
- Longevity
- Managed Care
- Maternal Health
- Medical Device
- Medical Education
- Men's Health
- Mental Health
- Minority Founders
- Neurology
- New Practice
- Open Data
- Orthopedics
- Other - Disease Related
- Pain Management
- Palliative Care
- Pancreatic Cancer
- Parkinson's disease
- Patient and Provider Tools
- Patient Education
- Patient Power Tools!
- Payer Innovations
- Pediatric care
- Pet Projects
- PharmaTech
- Population Health
- Precision Medicine
- Prevention
- Public Health
- Pulmonary/ Asthma
- Rare Diseases
- Regenerative Medicine
- Rheumatoid Arthritis
- Sexual Health
- Substance Abuse
- Wearables
- Women(s) Health
All Categories
Sponsors of NOLA Health Innovators community
New Orleans Business Alliance
Ochsner Health System
Blue Cross and Blue Shield of Lousiana
Stone Pigman Walther Wittmann
Capital One
LookFar
Propeller
The Warehouse
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.